Clinical trials in Hartford, CT

58 recruiting studies have a site in or near Hartford, CT, Connecticut.

Top conditions here

All conditions

Showing 40 of 58 studies

RecruitingPhase 3NCT07213674

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

Sponsor: Amgen

Hartford, CT · +45 more sites

RecruitingPhase 3NCT03150693

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

Sponsor: Alliance for Clinical Trials in Oncology

Hartford, CT · New Haven, CT · +452 more sites

RecruitingPhase 3NCT04267848

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Sponsor: National Cancer Institute (NCI)

Derby, CT · Fairfield, CT · Greenwich, CT · +1147 more sites

RecruitingPhase 2NCT06317662

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Sponsor: National Cancer Institute (NCI)

Hartford, CT · New Haven, CT · +113 more sites

RecruitingPhase 3NCT06498635

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Sponsor: National Cancer Institute (NCI)

Avon, CT · Hartford, CT · Manchester, CT · +278 more sites

RecruitingNot applicableNCT07238556

A Novel Digital Tool Clinicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors

Sponsor: University of Connecticut

Farmington, CT · Hartford, CT · Storrs, CT

RecruitingPhase 3NCT06736574

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

Sponsor: Cytokinetics

Bridgeport, CT · Hartford, CT · New Haven, CT · +85 more sites

RecruitingPhase 3NCT07007312

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Sponsor: Kura Oncology, Inc.

Hartford, CT · New Haven, CT · +42 more sites

RecruitingPhase 2NCT06031688

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Sponsor: SWOG Cancer Research Network

Derby, CT · Fairfield, CT · Glastonbury, CT · +275 more sites

RecruitingPhase 1 / Phase 2NCT07070232

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

Sponsor: BioNTech SE

Hartford, CT · New Haven, CT · +17 more sites

RecruitingNot applicableNCT06374238

Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain

Sponsor: University of Pittsburgh

Hartford, CT · +13 more sites

RecruitingPhase 3NCT04844606

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

Sponsor: Eli Lilly and Company

Hartford, CT · +10 more sites

RecruitingPhase 3NCT05509777

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

Sponsor: Eli Lilly and Company

Hartford, CT · +14 more sites

RecruitingPhase 2NCT07410507

A Study of Brenipatide in Adult Participants With Schizophrenia

Sponsor: Eli Lilly and Company

Hartford, CT · New Haven, CT · +30 more sites

RecruitingPhase 3NCT07158242

A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to Severely Active Ulcerative Colitis

Sponsor: Hoffmann-La Roche

Hartford, CT · +7 more sites

RecruitingPhase 3NCT07228832

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

Sponsor: Summit Therapeutics

Hartford, CT · New Haven, CT · Norwich, CT · +109 more sites

RecruitingPhase 3NCT05923073

A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

Sponsor: Janssen Research & Development, LLC

Hartford, CT · +13 more sites

RecruitingNot applicableNCT06735833

MMA Embolization for Refractory Chronic Migraine

Sponsor: Cerenovus, Part of DePuy Synthes Products, Inc.

Hartford, CT · +7 more sites

RecruitingPhase 3NCT07164443

A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

Sponsor: Janssen Research & Development, LLC

Hartford, CT · +53 more sites

RecruitingPhase 3NCT07196748

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

Sponsor: Janssen Research & Development, LLC

Danbury, CT · Hartford, CT · +54 more sites

RecruitingPhase 3NCT04649242

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

Sponsor: Pfizer

Cromwell, CT · Hartford, CT · Stamford, CT · +166 more sites

RecruitingPhase 2 / Phase 3NCT05076175

A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis

Sponsor: Bristol-Myers Squibb

Hartford, CT · +35 more sites

RecruitingPhase not listedNCT06777368

REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE

Sponsor: Medtronic Cardiovascular

Hartford, CT · New Haven, CT · +69 more sites

RecruitingPhase not listedNCT06433752

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

Sponsor: TG Therapeutics, Inc.

Farmington, CT · Hartford, CT · +107 more sites

RecruitingNot applicableNCT07214532

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Sponsor: Natera, Inc.

Hartford, CT · New Haven, CT · +47 more sites

RecruitingPhase 2 / Phase 3NCT06780670

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

Sponsor: Novartis Pharmaceuticals

Hartford, CT · +34 more sites

RecruitingPhase 3NCT04293562

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Sponsor: Children's Oncology Group

Hartford, CT · New Haven, CT · +184 more sites

RecruitingNot applicableNCT06035120

An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema

Sponsor: Pulmonx Corporation

Hartford, CT · +19 more sites

RecruitingPhase not listedNCT04994015

Parkinson's Foundation PD GENEration Genetic Registry

Sponsor: Parkinson's Foundation

Farmington, CT · Hartford, CT · +61 more sites

RecruitingPhase 3NCT05879926

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Sponsor: NRG Oncology

Avon, CT · Bridgeport, CT · Danbury, CT · +1223 more sites

RecruitingPhase not listedNCT02418442

Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry

Sponsor: Duke University

Hartford, CT · New Haven, CT · +73 more sites

RecruitingPhase 1 / Phase 2NCT04726241

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Sponsor: PedAL BCU, LLC

Hartford, CT · New Haven, CT · +162 more sites

RecruitingPhase not listedNCT00271180

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

Sponsor: Medtronic

Hartford, CT · New Haven, CT · +111 more sites

RecruitingPhase not listedNCT05489705

A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)

Sponsor: Bristol-Myers Squibb

Hartford, CT · +59 more sites

RecruitingPhase 2 / Phase 3NCT05431088

A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD

Sponsor: Pfizer

Hartford, CT · New Haven, CT · +44 more sites

RecruitingPhase not listedNCT04398628

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

Sponsor: American Thrombosis and Hemostasis Network

Hartford, CT · New Haven, CT · +74 more sites

RecruitingPhase 3NCT05303064

Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder

Sponsor: Alkermes, Inc.

Hartford, CT · +25 more sites

RecruitingNot applicableNCT05685303

Alleviant ALLAY-HF Study

Sponsor: Alleviant Medical, Inc.

Hartford, CT · +55 more sites

RecruitingNot applicableNCT06484621

Motivating Increases in Physical Activity for Prevention of Weight Regain After Metabolic Bariatric Surgery

Sponsor: Hartford Hospital

Hartford, CT

RecruitingPhase 3NCT05812807

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Sponsor: Alliance for Clinical Trials in Oncology

Bridgeport, CT · Danbury, CT · Derby, CT · +825 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.